Proteinase-activated receptor 2 may drive cancer progression by facilitating TGF-β signaling

18Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

The G protein-coupled receptor proteinase-activated receptor 2 (PAR2) has been implicated in various aspects of cellular physiology including inflammation, obesity and cancer. In cancer, it usually acts as a driver of cancer progression in various tumor types by promoting invasion and metastasis in response to activation by serine proteinases. Recently, we discovered another mode through which PAR2 may enhance tumorigenesis: crosstalk with transforming growth factor-β (TGF-β) signaling to promote TGF-β1-induced cell migration/invasion and invasion-associated gene expression in ductal pancreatic adenocarcinoma (PDAC) cells. In this chapter, we review what is known about the cellular TGF-β responses and signaling pathways affected by PAR2 expression, the signaling activities of PAR2 required for promoting TGF-β signaling, and the potential molecular mechanism(s) that underlie(s) the TGF-β signaling-promoting effect. Since PAR2 is activated through various serine proteinases and biased agonists, it may couple TGF-β signaling to a diverse range of other physiological processes that may or may not predispose cells to cancer development such as local inflammation, systemic coagulation and pathogen infection.

Cite

CITATION STYLE

APA

Ungefroren, H., Witte, D., Rauch, B. H., Settmacher, U., Lehnert, H., Gieseler, F., & Kaufmann, R. (2017, November 22). Proteinase-activated receptor 2 may drive cancer progression by facilitating TGF-β signaling. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms18112494

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free